Share your opinion and earn yourself a free Motley Fool premium report!

We are looking for Fools to join a 75 minute online independent market research forum on 15th / 16th December.

To find out more and express your interest please click here

What This Top Dividend Portfolio Is Holding Now: GlaxoSmithKline plc, Royal Dutch Shell Plc And Antofagasta plc

GlaxoSmithKline plc (LON:GSK), Royal Dutch Shell Plc (LON:RDSB) and Antofagasta (LON:ANTO) are favoured holdings of Merchants Trust plc (LON:MRCH).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Merchants Trust (LSE: MRCH) has delivered 33 consecutive years of dividend increases, and carries a trailing yield of 4.8%. Picking great dividend shares has helped Merchants outperform the FTSE All-Share Index over the past three, five and 10 years.

Heavyweight high yielder GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US), biggest holding and top yielder Royal Dutch Shell (LSE: RDSB) and new buy Antofagasta (LSE: ANTO) catch my eye in Merchants’ portfolio.

GlaxoSmithKline

Top FTSE 100 pharmaceuticals firm GlaxoSmithKline still does blockbuster drugs, but Merchants likes the way the company has been consolidating its global leadership positions in vaccines and consumer health, where there are “scale advantages” and “limited risk from generic competition”.

Earlier this month, Glaxo’s management set out its expectations for the reconfigured group. The Board anticipates an earnings decline in the current year at a percentage rate in the high teens, but expects to deliver a compound annual growth rate of mid-to-high single digits over the five-year period 2016-2020.

Management intends to peg the dividend at 80p a share this year and for the next two years. The payout equates to an annual yield of 5.5% for buyers of the shares at the current price of 1,442p. There’ll also be an additional 20p special dividend this year. From 2018, the prospects for dividend increases look good, if management delivers the mid-to-high single digits earnings growth it expects.

Royal Dutch Shell

Like Glaxo, oil supermajor Shell has put a near-term dividend increase on hold. The company has said it intends to pay an unchanged $1.88 a share this year — which may extend to next year, with management guiding on “at least that amount in 2016”.

At current exchange rates, the dollar dividend translates into a sterling payout of 121.3p, giving a yield of 6.1% for buyers of the shares at the current price of 2,000p.

The reason for the temporary halt to a dividend increase is Shell’s agreed £47bn acquisition of BG Group, announced last month. This deal is set to cement Shell’s leading position in the global LNG market and give the company a significant stake in attractive Brazilian assets. That should be good for shareholders’ dividends in the long run, and Merchants Trust is “supportive of the rationale for this deal”.

Antofagasta

Merchants has taken a new position in low-cost copper producer Antofagasta, explaining:

“Copper is an attractive commodity as supply is limited and increasingly expensive to develop whilst demand is broadly spread. Over time supply constraints should lead to a price recovery from depressed levels. The company has one of strongest balance sheets in the sector and is reasonably priced”.

Antofagasta’s dividend yield is a lowly 1.75% in the current subdued environment, but the company has a history of regularly returning excess capital to shareholders via special dividends when business is booming. At the current depressed share price of 775p, the kind of payouts we’ve seen on occasions in the past — and may see again in the future when the copper price recovers — would equate to a yield of 8%-9% during those years.

G A Chester has no position in any shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Night Takeoff Of The American Space Shuttle
Investing Articles

A SpaceX IPO could light a fire under this FTSE 100 stock

Shareholders of this FTSE 100 investment trust may have just got an early Christmas present from Space Exploration Technologies (SpaceX).

Read more »

Portrait Of Senior Couple Climbing Hill On Hike Through Countryside In Lake District UK Together
Investing Articles

Can dividends REALLY provide a second income you can live on?

Achieving a strong and sustained passive income in retirement may be easier than you think, even as yields on UK…

Read more »

Market Movers

33p penny stock Made Tech could be set for huge gains in 2026, if City analysts are right

This penny stock just experienced a sharp move higher. However, analysts reckon that there are plenty more gains to come…

Read more »

Elevated view over city of London skyline
Investing Articles

FTSE shares: a simple way to build long-term wealth?

Christopher Ruane explains some factors he thinks an investor should consider when trying to build wealth by investing in FTSE…

Read more »

Investing Articles

Will the soaring BP share price surge 88% in 2026?

BP's share price has risen by double-digit percentages in 2025 -- and some analysts think even greater gains could be…

Read more »

Belfast City Sunset with colorful twilight over Lagan Weir Pedestrian and Cycle Bridge spanning over the Lagan River in downtown Belfast
Investing Articles

Here’s what £5,000 put into HSBC shares in January would be worth now!

Would someone who bought HSBC shares back in January now be sitting on a paper profit or loss? Christopher Ruane…

Read more »

Percy Pig Ocado van outside distribution centre
Investing Articles

Down 91%, is there any hope left for Ocado shares?

Down 91% in five years, is the writing on the wall for Ocado shares? Our writer doesn't necessarily think so…

Read more »

UK financial background: share prices and stock graph overlaid on an image of the Union Jack
Investing Articles

It’s the most popular UK stock in 2025 but hasn’t grown in 5 years! What’s going on?

Harvey Jones is baffled by the sheer popularity of this UK stock. Its shares have hardly grown in recent years…

Read more »